3. Sahoo A. The Future of R&D Outsourcing 2010;Business Insights.
4. Fletcher AJ, Edwards LD, Fox AW, Stonier P. Chapter 10, Phase I: The first opportunity for extrapolation from Animal data to human exposure. Principles and practice of Pharmaceutical Medicine c2002;West Sussex (UK): John Wiley&Sons, Ltd. 95-114.
5. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, Schacht SL. How to improve R&D productivity: the pharmaceutical industrys grand challenge. Nat Rev Drug Discov 2010;9:203-214.
6. Guideline for Investigational New Drug application 2008 Korea Food&Drug Administration.
7. Kayser O, Müller RH. Chapter 11, Drug approval in the European Union and the United States. Pharmaceutical Biotechnology Drug Discovery and Clinical Applications c2004;2nd ed. Weinheim (Germany): Wiley-VCH Verlag GmbH&Co. KGaA. 201-210.
8. Dickson M, Gagnon P. Key factors in the rising cost of new drug discovery and development. Nat Rev Drug Discov 2004;3:417-429.
9. Lacasse FX, Larouche R, Tanguay M. Early phases in drug development. GOR 2005;7:69-73.
10. Guideline for evaluation of bridging data 2008 Korea Food&Drug Administration.
11. Wax PM. Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act. Ann Intern Med 1995;122:456-461.
12. Philipson TJ, Sun E. Is the Food and Drug Administration safe and effective? J Econ Persp 2008;22:85-102.
13. Katzung BG. Chapter 5, Development & regulation of drugs. Basic & Clinical Pharmacology c2009;11th ed. New York (US): The McGraw-Hill Companies, Inc. 67-76.
14. Kishore R, Tabor E. Overview of the FDA Amendment Act of 2007: Its effect on the drug development landscape. Drug Inf J 2009;44:469-475.
15. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ 2003;22:151-185.
16. DiMasi JA, Hansen RW, Grabowski HG, Lasagna L. Cost of innovation in the pharmaceutical industry. J Health Econ 1991;10:107-142.
17. Munos B. Lessons from 60 years of pharmaceutical innovation. Nat Rev Drug Discov 2009;8:959-968.
20. Press release. Korea National Enterprise for Clinical Trials 2010;02. 17.